A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/135 (2006.01)
Patent
CA 2198217
Selegiline, or a pharmaceutically acceptable salt form of selegiline, is administered to mammals commencing at a point in time at which at least 50 % of the mammal's life span is completed, with the administration continuing on a periodic but regular basis over the remaining life span of the mammal. The treatment, which shifts the survival curve, is especially useful for dogs.
De la sélégiline, ou une forme sodée pharmaceutiquement acceptable de la sélégiline, est administrée à des mammifères. Cette administration débute lorsqu'au moins la moitié de la durée de vie du mammifère est écoulée, et se poursuit sur une base périodique mais régulière pendant la durée de vie restante du mammifère. Ce traitement modifiant la courbe de survie est notamment utile pour les chiens.
Ruehl William W.
Stevens David R.
Deprenyl Animal Health Inc.
Deprenyl Inc. Usa
Torys Llp
LandOfFree
Use of selegiline to prolong life span does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of selegiline to prolong life span, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of selegiline to prolong life span will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1365158